0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-5E19017
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Fungal Drugs for Treatment of Tinea Market Research Report 2025
BUY CHAPTERS

Global Fungal Drugs for Treatment of Tinea Market Research Report 2025

Code: QYRE-Auto-5E19017
Report
March 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fungal Drugs for Treatment of Tinea Market Size

The global market for Fungal Drugs for Treatment of Tinea was valued at US$ 3542 million in the year 2024 and is projected to reach a revised size of US$ 4694 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Fungal Drugs for Treatment of Tinea Market

Fungal Drugs for Treatment of Tinea Market

Fungal drugs for the treatment of tinea refer to a class of antifungal medications specifically used to treat skin infections caused by dermatophytes, commonly known as tinea or ringworm. These infections affect various parts of the body, such as the scalp (tinea capitis), feet (tinea pedis), body (tinea corporis), and groin (tinea cruris). Antifungal drugs, including topical treatments like creams, lotions, and sprays, as well as systemic oral medications, work by inhibiting the growth of the fungi or directly killing the fungus responsible for the infection. Common active ingredients in these medications include terbinafine, clotrimazole, miconazole, and itraconazole.
Market Driver: The growing prevalence of tinea infections globally is a major driver for the fungal drugs market. These infections, which can affect a wide range of individuals regardless of age or gender, are common in areas with warm, humid climates and among populations with compromised immune systems. As awareness of fungal infections and their impact on health increases, there is a rising demand for effective and accessible treatments. Additionally, the expansion of over-the-counter (OTC) antifungal treatments has made these drugs more widely available to consumers, further boosting market growth. The ongoing research into novel antifungal agents and the development of more effective and targeted treatments also contribute to market expansion.
Market Challenge: A significant challenge for the fungal drugs market is the growing concern of antifungal resistance. Overuse and misuse of antifungal treatments can lead to resistance, making some fungal infections harder to treat. This not only poses a challenge to the effectiveness of existing drugs but also increases the need for the development of new and more potent antifungal agents. Furthermore, while there are numerous topical treatments available, many patients with severe or recurrent infections may require systemic therapy, which is often more expensive and comes with potential side effects. The high cost of new antifungal drugs and regulatory hurdles in bringing them to market also slow down growth and limit patient access.
This report aims to provide a comprehensive presentation of the global market for Fungal Drugs for Treatment of Tinea, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Drugs for Treatment of Tinea.
The Fungal Drugs for Treatment of Tinea market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fungal Drugs for Treatment of Tinea market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fungal Drugs for Treatment of Tinea companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Fungal Drugs for Treatment of Tinea Market Report

Report Metric Details
Report Name Fungal Drugs for Treatment of Tinea Market
Accounted market size in year US$ 3542 million
Forecasted market size in 2031 US$ 4694 million
CAGR 4.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Bausch Health, Bayer, Kaken Pharmaceutical, Gufic Biosciences, Galderma, Perrigo, Padagis, GSK, Novartis, Shandong Jingwei Pharmaceutical, Jiangsu Zhiyuan Pharmaceutical, Sandoz, Ultratech India, Teva Pharmaceuticals, Hubei Hengan Fulin, Chengdu Beite Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Tianjin Lisheng Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Harbin Sanlian Pharmaceuticals, Hainan Kangzhi Pharmaceuticals, Guilin Huaxin Pharmaceuticals, Shandong Qilu Pharmaceuticals, Jiangsu Yunyang Group Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Fungal Drugs for Treatment of Tinea company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Fungal Drugs for Treatment of Tinea Market growing?

Ans: The Fungal Drugs for Treatment of Tinea Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Fungal Drugs for Treatment of Tinea Market size in 2031?

Ans: The Fungal Drugs for Treatment of Tinea Market size in 2031 will be US$ 4694 million.

Who are the main players in the Fungal Drugs for Treatment of Tinea Market report?

Ans: The main players in the Fungal Drugs for Treatment of Tinea Market are Johnson & Johnson, Bausch Health, Bayer, Kaken Pharmaceutical, Gufic Biosciences, Galderma, Perrigo, Padagis, GSK, Novartis, Shandong Jingwei Pharmaceutical, Jiangsu Zhiyuan Pharmaceutical, Sandoz, Ultratech India, Teva Pharmaceuticals, Hubei Hengan Fulin, Chengdu Beite Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Tianjin Lisheng Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Harbin Sanlian Pharmaceuticals, Hainan Kangzhi Pharmaceuticals, Guilin Huaxin Pharmaceuticals, Shandong Qilu Pharmaceuticals, Jiangsu Yunyang Group Pharmaceuticals

What are the Application segmentation covered in the Fungal Drugs for Treatment of Tinea Market report?

Ans: The Applications covered in the Fungal Drugs for Treatment of Tinea Market report are Hospital Pharmacy, Retail Pharmacy, Online

What are the Type segmentation covered in the Fungal Drugs for Treatment of Tinea Market report?

Ans: The Types covered in the Fungal Drugs for Treatment of Tinea Market report are Topical Drugs, Oral Drugs

Recommended Reports

Topical & Oral Antifungals

Fungal Infection Therapeutics

Antifungal Market Insights

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Topical Drugs
1.2.3 Oral Drugs
1.3 Market by Application
1.3.1 Global Fungal Drugs for Treatment of Tinea Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fungal Drugs for Treatment of Tinea Market Perspective (2020-2031)
2.2 Global Fungal Drugs for Treatment of Tinea Growth Trends by Region
2.2.1 Global Fungal Drugs for Treatment of Tinea Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fungal Drugs for Treatment of Tinea Historic Market Size by Region (2020-2025)
2.2.3 Fungal Drugs for Treatment of Tinea Forecasted Market Size by Region (2026-2031)
2.3 Fungal Drugs for Treatment of Tinea Market Dynamics
2.3.1 Fungal Drugs for Treatment of Tinea Industry Trends
2.3.2 Fungal Drugs for Treatment of Tinea Market Drivers
2.3.3 Fungal Drugs for Treatment of Tinea Market Challenges
2.3.4 Fungal Drugs for Treatment of Tinea Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fungal Drugs for Treatment of Tinea Players by Revenue
3.1.1 Global Top Fungal Drugs for Treatment of Tinea Players by Revenue (2020-2025)
3.1.2 Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Players (2020-2025)
3.2 Global Top Fungal Drugs for Treatment of Tinea Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fungal Drugs for Treatment of Tinea Revenue
3.4 Global Fungal Drugs for Treatment of Tinea Market Concentration Ratio
3.4.1 Global Fungal Drugs for Treatment of Tinea Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fungal Drugs for Treatment of Tinea Revenue in 2024
3.5 Global Key Players of Fungal Drugs for Treatment of Tinea Head office and Area Served
3.6 Global Key Players of Fungal Drugs for Treatment of Tinea, Product and Application
3.7 Global Key Players of Fungal Drugs for Treatment of Tinea, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fungal Drugs for Treatment of Tinea Breakdown Data by Type
4.1 Global Fungal Drugs for Treatment of Tinea Historic Market Size by Type (2020-2025)
4.2 Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Type (2026-2031)
5 Fungal Drugs for Treatment of Tinea Breakdown Data by Application
5.1 Global Fungal Drugs for Treatment of Tinea Historic Market Size by Application (2020-2025)
5.2 Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Fungal Drugs for Treatment of Tinea Market Size (2020-2031)
6.2 North America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025)
6.4 North America Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fungal Drugs for Treatment of Tinea Market Size (2020-2031)
7.2 Europe Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025)
7.4 Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size (2020-2031)
8.2 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Region (2020-2025)
8.4 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fungal Drugs for Treatment of Tinea Market Size (2020-2031)
9.2 Latin America Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025)
9.4 Latin America Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size (2020-2031)
10.2 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025)
10.4 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Fungal Drugs for Treatment of Tinea Introduction
11.1.4 Johnson & Johnson Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Fungal Drugs for Treatment of Tinea Introduction
11.2.4 Bausch Health Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.2.5 Bausch Health Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Fungal Drugs for Treatment of Tinea Introduction
11.3.4 Bayer Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Kaken Pharmaceutical
11.4.1 Kaken Pharmaceutical Company Details
11.4.2 Kaken Pharmaceutical Business Overview
11.4.3 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Introduction
11.4.4 Kaken Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.4.5 Kaken Pharmaceutical Recent Development
11.5 Gufic Biosciences
11.5.1 Gufic Biosciences Company Details
11.5.2 Gufic Biosciences Business Overview
11.5.3 Gufic Biosciences Fungal Drugs for Treatment of Tinea Introduction
11.5.4 Gufic Biosciences Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.5.5 Gufic Biosciences Recent Development
11.6 Galderma
11.6.1 Galderma Company Details
11.6.2 Galderma Business Overview
11.6.3 Galderma Fungal Drugs for Treatment of Tinea Introduction
11.6.4 Galderma Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.6.5 Galderma Recent Development
11.7 Perrigo
11.7.1 Perrigo Company Details
11.7.2 Perrigo Business Overview
11.7.3 Perrigo Fungal Drugs for Treatment of Tinea Introduction
11.7.4 Perrigo Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.7.5 Perrigo Recent Development
11.8 Padagis
11.8.1 Padagis Company Details
11.8.2 Padagis Business Overview
11.8.3 Padagis Fungal Drugs for Treatment of Tinea Introduction
11.8.4 Padagis Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.8.5 Padagis Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Fungal Drugs for Treatment of Tinea Introduction
11.9.4 GSK Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Fungal Drugs for Treatment of Tinea Introduction
11.10.4 Novartis Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Shandong Jingwei Pharmaceutical
11.11.1 Shandong Jingwei Pharmaceutical Company Details
11.11.2 Shandong Jingwei Pharmaceutical Business Overview
11.11.3 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Introduction
11.11.4 Shandong Jingwei Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.11.5 Shandong Jingwei Pharmaceutical Recent Development
11.12 Jiangsu Zhiyuan Pharmaceutical
11.12.1 Jiangsu Zhiyuan Pharmaceutical Company Details
11.12.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
11.12.3 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Introduction
11.12.4 Jiangsu Zhiyuan Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.12.5 Jiangsu Zhiyuan Pharmaceutical Recent Development
11.13 Sandoz
11.13.1 Sandoz Company Details
11.13.2 Sandoz Business Overview
11.13.3 Sandoz Fungal Drugs for Treatment of Tinea Introduction
11.13.4 Sandoz Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.13.5 Sandoz Recent Development
11.14 Ultratech India
11.14.1 Ultratech India Company Details
11.14.2 Ultratech India Business Overview
11.14.3 Ultratech India Fungal Drugs for Treatment of Tinea Introduction
11.14.4 Ultratech India Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.14.5 Ultratech India Recent Development
11.15 Teva Pharmaceuticals
11.15.1 Teva Pharmaceuticals Company Details
11.15.2 Teva Pharmaceuticals Business Overview
11.15.3 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.15.4 Teva Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.15.5 Teva Pharmaceuticals Recent Development
11.16 Hubei Hengan Fulin
11.16.1 Hubei Hengan Fulin Company Details
11.16.2 Hubei Hengan Fulin Business Overview
11.16.3 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Introduction
11.16.4 Hubei Hengan Fulin Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.16.5 Hubei Hengan Fulin Recent Development
11.17 Chengdu Beite Pharmaceuticals
11.17.1 Chengdu Beite Pharmaceuticals Company Details
11.17.2 Chengdu Beite Pharmaceuticals Business Overview
11.17.3 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.17.4 Chengdu Beite Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.17.5 Chengdu Beite Pharmaceuticals Recent Development
11.18 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
11.18.1 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Details
11.18.2 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
11.18.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.18.4 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.18.5 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Development
11.19 Tianjin Lisheng Pharmaceuticals
11.19.1 Tianjin Lisheng Pharmaceuticals Company Details
11.19.2 Tianjin Lisheng Pharmaceuticals Business Overview
11.19.3 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.19.4 Tianjin Lisheng Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.19.5 Tianjin Lisheng Pharmaceuticals Recent Development
11.20 Shandong Luoxin Pharmaceuticals
11.20.1 Shandong Luoxin Pharmaceuticals Company Details
11.20.2 Shandong Luoxin Pharmaceuticals Business Overview
11.20.3 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.20.4 Shandong Luoxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.20.5 Shandong Luoxin Pharmaceuticals Recent Development
11.21 Harbin Sanlian Pharmaceuticals
11.21.1 Harbin Sanlian Pharmaceuticals Company Details
11.21.2 Harbin Sanlian Pharmaceuticals Business Overview
11.21.3 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.21.4 Harbin Sanlian Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.21.5 Harbin Sanlian Pharmaceuticals Recent Development
11.22 Hainan Kangzhi Pharmaceuticals
11.22.1 Hainan Kangzhi Pharmaceuticals Company Details
11.22.2 Hainan Kangzhi Pharmaceuticals Business Overview
11.22.3 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.22.4 Hainan Kangzhi Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.22.5 Hainan Kangzhi Pharmaceuticals Recent Development
11.23 Guilin Huaxin Pharmaceuticals
11.23.1 Guilin Huaxin Pharmaceuticals Company Details
11.23.2 Guilin Huaxin Pharmaceuticals Business Overview
11.23.3 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.23.4 Guilin Huaxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.23.5 Guilin Huaxin Pharmaceuticals Recent Development
11.24 Shandong Qilu Pharmaceuticals
11.24.1 Shandong Qilu Pharmaceuticals Company Details
11.24.2 Shandong Qilu Pharmaceuticals Business Overview
11.24.3 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.24.4 Shandong Qilu Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.24.5 Shandong Qilu Pharmaceuticals Recent Development
11.25 Jiangsu Yunyang Group Pharmaceuticals
11.25.1 Jiangsu Yunyang Group Pharmaceuticals Company Details
11.25.2 Jiangsu Yunyang Group Pharmaceuticals Business Overview
11.25.3 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Introduction
11.25.4 Jiangsu Yunyang Group Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025)
11.25.5 Jiangsu Yunyang Group Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Topical Drugs
 Table 3. Key Players of Oral Drugs
 Table 4. Global Fungal Drugs for Treatment of Tinea Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Fungal Drugs for Treatment of Tinea Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2020-2025)
 Table 8. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2026-2031)
 Table 10. Fungal Drugs for Treatment of Tinea Market Trends
 Table 11. Fungal Drugs for Treatment of Tinea Market Drivers
 Table 12. Fungal Drugs for Treatment of Tinea Market Challenges
 Table 13. Fungal Drugs for Treatment of Tinea Market Restraints
 Table 14. Global Fungal Drugs for Treatment of Tinea Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Fungal Drugs for Treatment of Tinea Market Share by Players (2020-2025)
 Table 16. Global Top Fungal Drugs for Treatment of Tinea Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Drugs for Treatment of Tinea as of 2024)
 Table 17. Ranking of Global Top Fungal Drugs for Treatment of Tinea Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Fungal Drugs for Treatment of Tinea Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Fungal Drugs for Treatment of Tinea, Headquarters and Area Served
 Table 20. Global Key Players of Fungal Drugs for Treatment of Tinea, Product and Application
 Table 21. Global Key Players of Fungal Drugs for Treatment of Tinea, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Fungal Drugs for Treatment of Tinea Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2020-2025)
 Table 25. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Type (2026-2031)
 Table 27. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2020-2025)
 Table 29. Global Fungal Drugs for Treatment of Tinea Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Application (2026-2031)
 Table 31. North America Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Fungal Drugs for Treatment of Tinea Product
 Table 49. Johnson & Johnson Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 50. Johnson & Johnson Recent Development
 Table 51. Bausch Health Company Details
 Table 52. Bausch Health Business Overview
 Table 53. Bausch Health Fungal Drugs for Treatment of Tinea Product
 Table 54. Bausch Health Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 55. Bausch Health Recent Development
 Table 56. Bayer Company Details
 Table 57. Bayer Business Overview
 Table 58. Bayer Fungal Drugs for Treatment of Tinea Product
 Table 59. Bayer Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 60. Bayer Recent Development
 Table 61. Kaken Pharmaceutical Company Details
 Table 62. Kaken Pharmaceutical Business Overview
 Table 63. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product
 Table 64. Kaken Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 65. Kaken Pharmaceutical Recent Development
 Table 66. Gufic Biosciences Company Details
 Table 67. Gufic Biosciences Business Overview
 Table 68. Gufic Biosciences Fungal Drugs for Treatment of Tinea Product
 Table 69. Gufic Biosciences Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 70. Gufic Biosciences Recent Development
 Table 71. Galderma Company Details
 Table 72. Galderma Business Overview
 Table 73. Galderma Fungal Drugs for Treatment of Tinea Product
 Table 74. Galderma Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 75. Galderma Recent Development
 Table 76. Perrigo Company Details
 Table 77. Perrigo Business Overview
 Table 78. Perrigo Fungal Drugs for Treatment of Tinea Product
 Table 79. Perrigo Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 80. Perrigo Recent Development
 Table 81. Padagis Company Details
 Table 82. Padagis Business Overview
 Table 83. Padagis Fungal Drugs for Treatment of Tinea Product
 Table 84. Padagis Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 85. Padagis Recent Development
 Table 86. GSK Company Details
 Table 87. GSK Business Overview
 Table 88. GSK Fungal Drugs for Treatment of Tinea Product
 Table 89. GSK Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 90. GSK Recent Development
 Table 91. Novartis Company Details
 Table 92. Novartis Business Overview
 Table 93. Novartis Fungal Drugs for Treatment of Tinea Product
 Table 94. Novartis Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 95. Novartis Recent Development
 Table 96. Shandong Jingwei Pharmaceutical Company Details
 Table 97. Shandong Jingwei Pharmaceutical Business Overview
 Table 98. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product
 Table 99. Shandong Jingwei Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 100. Shandong Jingwei Pharmaceutical Recent Development
 Table 101. Jiangsu Zhiyuan Pharmaceutical Company Details
 Table 102. Jiangsu Zhiyuan Pharmaceutical Business Overview
 Table 103. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product
 Table 104. Jiangsu Zhiyuan Pharmaceutical Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 105. Jiangsu Zhiyuan Pharmaceutical Recent Development
 Table 106. Sandoz Company Details
 Table 107. Sandoz Business Overview
 Table 108. Sandoz Fungal Drugs for Treatment of Tinea Product
 Table 109. Sandoz Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 110. Sandoz Recent Development
 Table 111. Ultratech India Company Details
 Table 112. Ultratech India Business Overview
 Table 113. Ultratech India Fungal Drugs for Treatment of Tinea Product
 Table 114. Ultratech India Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 115. Ultratech India Recent Development
 Table 116. Teva Pharmaceuticals Company Details
 Table 117. Teva Pharmaceuticals Business Overview
 Table 118. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 119. Teva Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 120. Teva Pharmaceuticals Recent Development
 Table 121. Hubei Hengan Fulin Company Details
 Table 122. Hubei Hengan Fulin Business Overview
 Table 123. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product
 Table 124. Hubei Hengan Fulin Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 125. Hubei Hengan Fulin Recent Development
 Table 126. Chengdu Beite Pharmaceuticals Company Details
 Table 127. Chengdu Beite Pharmaceuticals Business Overview
 Table 128. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 129. Chengdu Beite Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 130. Chengdu Beite Pharmaceuticals Recent Development
 Table 131. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Details
 Table 132. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
 Table 133. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 134. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 135. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Development
 Table 136. Tianjin Lisheng Pharmaceuticals Company Details
 Table 137. Tianjin Lisheng Pharmaceuticals Business Overview
 Table 138. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 139. Tianjin Lisheng Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 140. Tianjin Lisheng Pharmaceuticals Recent Development
 Table 141. Shandong Luoxin Pharmaceuticals Company Details
 Table 142. Shandong Luoxin Pharmaceuticals Business Overview
 Table 143. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 144. Shandong Luoxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 145. Shandong Luoxin Pharmaceuticals Recent Development
 Table 146. Harbin Sanlian Pharmaceuticals Company Details
 Table 147. Harbin Sanlian Pharmaceuticals Business Overview
 Table 148. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 149. Harbin Sanlian Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 150. Harbin Sanlian Pharmaceuticals Recent Development
 Table 151. Hainan Kangzhi Pharmaceuticals Company Details
 Table 152. Hainan Kangzhi Pharmaceuticals Business Overview
 Table 153. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 154. Hainan Kangzhi Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 155. Hainan Kangzhi Pharmaceuticals Recent Development
 Table 156. Guilin Huaxin Pharmaceuticals Company Details
 Table 157. Guilin Huaxin Pharmaceuticals Business Overview
 Table 158. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 159. Guilin Huaxin Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 160. Guilin Huaxin Pharmaceuticals Recent Development
 Table 161. Shandong Qilu Pharmaceuticals Company Details
 Table 162. Shandong Qilu Pharmaceuticals Business Overview
 Table 163. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 164. Shandong Qilu Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 165. Shandong Qilu Pharmaceuticals Recent Development
 Table 166. Jiangsu Yunyang Group Pharmaceuticals Company Details
 Table 167. Jiangsu Yunyang Group Pharmaceuticals Business Overview
 Table 168. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product
 Table 169. Jiangsu Yunyang Group Pharmaceuticals Revenue in Fungal Drugs for Treatment of Tinea Business (2020-2025) & (US$ Million)
 Table 170. Jiangsu Yunyang Group Pharmaceuticals Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Fungal Drugs for Treatment of Tinea Picture
 Figure 2. Global Fungal Drugs for Treatment of Tinea Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fungal Drugs for Treatment of Tinea Market Share by Type: 2024 VS 2031
 Figure 4. Topical Drugs Features
 Figure 5. Oral Drugs Features
 Figure 6. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Fungal Drugs for Treatment of Tinea Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Pharmacy Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Online Case Studies
 Figure 11. Fungal Drugs for Treatment of Tinea Report Years Considered
 Figure 12. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Fungal Drugs for Treatment of Tinea Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Fungal Drugs for Treatment of Tinea Market Share by Region: 2024 VS 2031
 Figure 15. Global Fungal Drugs for Treatment of Tinea Market Share by Players in 2024
 Figure 16. Global Fungal Drugs for Treatment of Tinea Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Fungal Drugs for Treatment of Tinea Revenue in 2024
 Figure 18. North America Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Fungal Drugs for Treatment of Tinea Market Share by Country (2020-2031)
 Figure 20. United States Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Fungal Drugs for Treatment of Tinea Market Share by Country (2020-2031)
 Figure 24. Germany Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share by Region (2020-2031)
 Figure 32. China Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Fungal Drugs for Treatment of Tinea Market Share by Country (2020-2031)
 Figure 40. Mexico Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Share by Country (2020-2031)
 Figure 44. Turkey Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Fungal Drugs for Treatment of Tinea Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Johnson & Johnson Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 48. Bausch Health Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 49. Bayer Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 50. Kaken Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 51. Gufic Biosciences Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 52. Galderma Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 53. Perrigo Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 54. Padagis Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 55. GSK Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 57. Shandong Jingwei Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 58. Jiangsu Zhiyuan Pharmaceutical Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 59. Sandoz Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 60. Ultratech India Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 62. Hubei Hengan Fulin Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 63. Chengdu Beite Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 64. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 65. Tianjin Lisheng Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 66. Shandong Luoxin Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 67. Harbin Sanlian Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 68. Hainan Kangzhi Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 69. Guilin Huaxin Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 70. Shandong Qilu Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 71. Jiangsu Yunyang Group Pharmaceuticals Revenue Growth Rate in Fungal Drugs for Treatment of Tinea Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS